TRAQinform IQ provides clinicians with lesion-level analysis offering earlier, clearer insights into patterns of treatment response heterogeneity than traditional imaging assessments. For patients ...
NeurAxis, Inc. (AMEX:NRXS) Q4 2025 Earnings Call Transcript March 19, 2026 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the NeurAxis, Inc. fourth quarter 2025 financial ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...
Before AI can transform healthcare, someone has to fix the infrastructure underneath it. As Senior Analytics Engineer ...
(“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic and debilitating conditions in children and adults, today ...
Last summer, a man’s brother-in-law suffered a fatal heart attack. The hospital bill for four hours of emergency care: $195,628. The man’s sister-in-law was ready to pay it. He asked her to wait. He ...
Last summer, a man’s brother-in-law suffered a fatal heart attack. The hospital bill for four hours of emergency care: $195,628. The man’s sister-in-law was ready to pay it. He asked her to wait. He ...
NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...
It’s been milestone after milestone for Neurent Medical, an Irish medtech company seeking to tackle chronic rhinitis.
Earlier today, Hyperfine Inc. released financial results for the quarter ending December 31, 2025. Before we begin, I'd like ...
Transforming healthcare underpayment detec AI in 2026 improves revenue recovery for U.S. hospitals facing $130 billion in annual losses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results